• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌铁负荷史是重型β地中海贫血成年患者患糖尿病和性腺功能减退的一个重要危险因素。

History of myocardial iron loading is a strong risk factor for diabetes mellitus and hypogonadism in adults with β thalassemia major.

作者信息

Ang Ai Leen, Tzoulis Ploutarchos, Prescott Emma, Davis Bernard A, Barnard Maria, Shah Farrukh T

机构信息

Department of Haematology, The Whittington Hospital, London, UK; Department of Haematology, Singapore General Hospital, Singapore.

出版信息

Eur J Haematol. 2014 Mar;92(3):229-36. doi: 10.1111/ejh.12224.

DOI:10.1111/ejh.12224
PMID:24164584
Abstract

Endocrinopathies are common complications of transfusional hemosiderosis among patients with β thalassemia major (TM). Previous studies had shown associations between some endocrinopathies and iron overload of the myocardium, liver and/or endocrine organs as assessed by MRI techniques. This retrospective analysis of 92 patients with TM (median age 36 yr) from a tertiary adult thalassemia unit in UK aimed to determine independent risk factors associated with endocrinopathies among these patients. Unlike previous studies, longitudinal data on routine measurements of iron load [worst myocardial and liver T2* values since 1999, worst LIC by MRI-R2 since 2008 and average 10-yr serum ferritin (SF)] up to April 2010 together with demographic features and age of initiating chelation were analyzed for associations with endocrinopathies. The most common endocrinopathies in this cohort were hypogonadism (67%) and diabetes mellitus (DM) (41%), and these were independently associated with myocardial T2* <20 ms (P < 0.001 and P = 0.008, respectively) and increased age (P = 0.002 and P = 0.016, respectively). DM and hypogonadism were independently associated with average SF >1250 μg/L (P = 0.003) and >2000 μg/L (P = 0.047), respectively. DM was also associated with initial detection of abnormal myocardial T2* at an older age (30 yr vs. 24 yr, P = 0.039). An abnormal myocardial T2* may therefore portend the development of DM and hypogonadism in patients with TM.

摘要

内分泌病是重型β地中海贫血(TM)患者输血性含铁血黄素沉着症的常见并发症。既往研究表明,通过MRI技术评估,某些内分泌病与心肌、肝脏和/或内分泌器官的铁过载之间存在关联。这项对英国一家三级成人地中海贫血治疗中心的92例TM患者(中位年龄36岁)进行的回顾性分析,旨在确定这些患者中与内分泌病相关的独立危险因素。与既往研究不同的是,分析了截至2010年4月的铁负荷常规测量的纵向数据[1999年以来最差的心肌和肝脏T2值、2008年以来MRI-R2测量的最差肝脏铁浓度(LIC)以及10年血清铁蛋白(SF)平均值],以及人口统计学特征和开始螯合治疗的年龄,以寻找与内分泌病的关联。该队列中最常见的内分泌病是性腺功能减退(67%)和糖尿病(DM)(41%),它们分别与心肌T2<20 ms独立相关(P<0.001和P=0.008)以及年龄增加独立相关(P=0.002和P=0.016)。DM和性腺功能减退分别与平均SF>1250μg/L(P=0.003)和>2000μg/L(P=0.047)独立相关。DM还与在较高年龄(30岁对24岁,P=0.039)首次检测到异常心肌T2有关。因此,异常心肌T2可能预示着TM患者发生DM和性腺功能减退。

相似文献

1
History of myocardial iron loading is a strong risk factor for diabetes mellitus and hypogonadism in adults with β thalassemia major.心肌铁负荷史是重型β地中海贫血成年患者患糖尿病和性腺功能减退的一个重要危险因素。
Eur J Haematol. 2014 Mar;92(3):229-36. doi: 10.1111/ejh.12224.
2
Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.重型和中间型地中海贫血中的内分泌病、代谢紊乱及铁过载:血清铁蛋白作为与肝脏和心脏T2*磁共振成像评估相关的诊断和预测标志物
Eur J Haematol. 2015 May;94(5):404-12. doi: 10.1111/ejh.12444. Epub 2014 Oct 18.
3
Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.β 重型地中海贫血症患者经医学治疗后的血清铁蛋白水平与内分泌异常。
Ann Hematol. 2012 Jul;91(7):1107-14. doi: 10.1007/s00277-012-1412-7. Epub 2012 Jan 28.
4
The impact of genotype on endocrine complications in thalassaemia major.基因型对重型地中海贫血内分泌并发症的影响。
Eur J Haematol. 2006 Aug;77(2):150-6. doi: 10.1111/j.1600-0609.2006.00681.x. Epub 2006 Jun 23.
5
[Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major].[磁共振成像T2*检测在重型β地中海贫血患者心脏和肝脏铁过载检测中的价值]
Nan Fang Yi Ke Da Xue Xue Bao. 2013 Feb;33(2):249-52.
6
Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre.性腺功能减退、糖尿病、甲状腺功能减退、甲状旁腺功能减退:1980年至2007年在费拉拉中心随访的重型地中海贫血患者中与铁过载及螯合疗法相关的发病率和患病率
Pediatr Endocrinol Rev. 2008 Oct;6 Suppl 1:158-69.
7
Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients.年轻地中海贫血患者肝脏、心肌和垂体铁沉积的MRI相关性研究。
J Pediatr Hematol Oncol. 2006 May;28(5):311-5. doi: 10.1097/01.mph.0000212915.22265.3b.
8
Pituitary iron and volume predict hypogonadism in transfusional iron overload.垂体铁含量和体积可预测输血性铁过载中的性腺功能减退症。
Am J Hematol. 2012 Feb;87(2):167-71. doi: 10.1002/ajh.22247. Epub 2011 Dec 27.
9
Risk factors associated with hypogonadism in β-thalassemia major patients: predictors for a frequent complication of a rare disease.重型β地中海贫血患者性腺功能减退的相关危险因素:一种罕见疾病常见并发症的预测因素
Postgrad Med. 2014 Sep;126(5):121-7. doi: 10.3810/pgm.2014.09.2806.
10
Cardiac complications and diabetes in thalassaemia major: a large historical multicentre study.地中海贫血症中的心脏并发症和糖尿病:一项大型历史性多中心研究。
Br J Haematol. 2013 Nov;163(4):520-7. doi: 10.1111/bjh.12557. Epub 2013 Sep 20.

引用本文的文献

1
Real-world complication burden and disease management paradigms in transfusion-related β-thalassaemia in Greece: Results from ULYSSES, an epidemiological, multicentre, retrospective cross-sectional study.希腊输血相关性β地中海贫血的真实世界并发症负担及疾病管理模式:来自ULYSSES的结果,一项流行病学、多中心、回顾性横断面研究
EJHaem. 2023 May 23;4(3):569-581. doi: 10.1002/jha2.695. eCollection 2023 Aug.
2
Approach to the management of β thalassemia major associated osteoporosis - A long-standing relationship revisited.β 地中海贫血所致骨质疏松症的管理方法-重新审视长期存在的关系。
Acta Biomed. 2022 Oct 26;93(5):e2022305. doi: 10.23750/abm.v93i5.13668.
3
Relationship between Serum Ferritin and Outcomes in β-Thalassemia: A Systematic Literature Review.
β地中海贫血患者血清铁蛋白与预后的关系:一项系统文献综述
J Clin Med. 2022 Jul 30;11(15):4448. doi: 10.3390/jcm11154448.
4
Screening for glucose dysregulation in β-thalassemia major (β-TM): An update of current evidences and personal experience.重型β地中海贫血(β-TM)患者葡萄糖调节异常的筛查:当前证据及个人经验的更新
Acta Biomed. 2022 Mar 14;93(1):e2022158. doi: 10.23750/abm.v93i1.12802.
5
The Influence of Cardiovascular Risk Factors and Hypogonadism on Cardiac Outcomes in an Aging Population of Beta-Thalassemia Patients.心血管危险因素和性腺功能减退对老年β地中海贫血患者心脏结局的影响
J Cardiovasc Dev Dis. 2021 Dec 21;9(1):3. doi: 10.3390/jcdd9010003.
6
Glucose Metabolism and Insulin Response to Oral Glucose Tolerance Test (OGTT) in Prepubertal Patients with Transfusion-Dependent β-thalassemia (TDT): A Long-Term Retrospective Analysis.输血依赖型β地中海贫血(TDT)青春期前患者的葡萄糖代谢及口服葡萄糖耐量试验(OGTT)的胰岛素反应:一项长期回顾性分析
Mediterr J Hematol Infect Dis. 2021 Sep 1;13(1):e2021051. doi: 10.4084/MJHID.2021.051. eCollection 2021.
7
The Pancreatic changes affecting glucose homeostasis in transfusion dependent β- thalassemia (TDT): a short review.影响输血依赖型β-地中海贫血(TDT)葡萄糖稳态的胰腺变化:简短综述。
Acta Biomed. 2021 Jul 1;92(3):e2021232. doi: 10.23750/abm.v92i3.11685.
8
Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia.输血依赖型β地中海贫血中betibeglogene autotemcel(Beti-cel)基因添加疗法的经济学评估
J Mark Access Health Policy. 2021 Jun 7;9(1):1922028. doi: 10.1080/20016689.2021.1922028.
9
Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohort.依赖输血的地中海贫血患者在使用去铁酮螯合治疗时发生内分泌并发症的风险因素:一项来自多中心全国队列的风险评估研究。
Haematologica. 2022 Feb 1;107(2):467-477. doi: 10.3324/haematol.2020.272419.
10
Diabetes Mellitus in Thalassaemia Major Patients: A Report from the Southeast of Iran.重型地中海贫血患者的糖尿病:来自伊朗东南部的报告。
J Clin Diagn Res. 2017 May;11(5):BC01-BC04. doi: 10.7860/JCDR/2017/24762.9806. Epub 2017 May 1.